Scientists discover a new way a disease-linked protein comes apart
Transthyretin amyloid disease (ATTR) is a progressive, life-threatening condition caused when the protein transthyretin (TTR) breaks apart and aggregates in the heart and other organs. One of the most common treatments, a drug called tafamidis, works by helping TTR stay intact—slowing how it normally unfolds and aggregates.
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
